AUTOIMMUNITY

Autoimmunity (ISSN 0891-6934) is a peer-reviewed international journal published by Taylor & Francis in the United Kingdom, dedicated to advancing the scientific understanding of autoimmune disorders. Released on a bimonthly basis, this subscription-based publication is indexed in the Science Citation Index (SCI) and maintains a stable academic standing, typically ranking in the third or fourth quartile of the Chinese Academy of Sciences journal classification for medical sciences, with a 2022 impact factor of 3.4. The journal’s scope encompasses both fundamental and clinical investigations into the pathogenesis, diagnostic methodologies, and therapeutic strategies for a wide array of autoimmune conditions, including rheumatoid arthritis, systemic lupus erythematosus, and multiple sclerosis. While the publication process is noted for its relatively efficient review cycle, the journal maintains rigorous standards for methodological soundness and scientific novelty, resulting in a competitive selection process that favors original contributions over repetitive studies. Consequently, Autoimmunity serves as a reputable venue for researchers seeking to disseminate high-quality, innovative findings in the field of autoimmunity to a specialized global audience.